Dosimetry and Health Effects of Diagnostic Applications of Radiopharmaceuticals with particular emphasis on the use in children an adolescents

Nuclear medicine contributes significantly to the health, healthcare and quality of life of European citizens, particularly in major clinical areas such as cancer and cardiovascular disease. The evaluation of the impact on patients' health of small and non-repetitive or less repetitive doses of radioactive substances, as currently used in diagnostic imaging procedures, has up to now not been addressed systematically in a European context.

The major aim of the project  PEDDOSE.NET is to provide a comprehensive report on the short-term and long-term safety of nuclear medicine diagnostic procedures including the new ICRP recommendations, epidemiological data and technical aspects of image production. The report will also include recommendations and guideline proposals for the application of radioactive pharmaceuticals to children. Missing data will be identified and proposals will be made for further research and/or clinical trials. The dissemination of results will be organized by EIBIR and its co-shareholder EANM.

As the consortium consists of the leading experts in Europe dealing with dosimetry of nuclear medicine the results of this support action will lead to improved patient radiation protection, to a further enhancement of the number of nuclear medicine procedures, to an immense increase of knowledge within the European Union and will bring Nuclear Medicine to a higher level within the global nuclear medicine community for the benefit of patients.

The project is funded by the European Commission within the 7^th Framework Programme with a financial contribution of 500.000 EUR. The 1,5-year project started in April 2010 and consists of 5 international scientific partners from seven countries, with EIBIR as coordinating partner.

For more information please visit the project website www.peddose.net